Medicina (Page 36)

Although antibodies induced by SARS-CoV-2 infection are largely protective, they do not completely protect against reinfection in young people, as evidenced through a longitudinal, prospective study of more than 3,000 young, healthy members of the US Marines Corps conducted by researchers at the Icahn School of Medicine at Mount SinaiContinuar Leyendo

Patients who have preexisting respiratory conditions such as asthma or chronic obstructive pulmonary disease (COPD) and live in areas with high levels of air pollution have a greater chance of hospitalization if they contract COVID-19, says a University of Cincinnati researcher. Cincinnati, April 15, 2021.-  Mendy, MD, PhD, assistant professorContinuar Leyendo

A new state-by-state analysis shows a statistical association between high adherence to mask wearing and reduced rates of COVID-19 in the U.S. Charlie Fischer and colleagues at the Boston University School of Public Health in Massachusetts present these findings in the open-access journal PLOS ONE on April 14. Boston, AprilContinuar Leyendo

A tiny protein of SARS-CoV-2, the coronavirus that gives rise to COVID-19, may have big implications for future treatments, according to a team of Penn State researchers. University Park, PA.- April 12, 2021.- Using a novel toolkit of approaches, the scientists uncovered the first full structure of the Nucleocapsid (N)Continuar Leyendo

A new study using human genetics suggests researchers should prioritize clinical trials of drugs that target two proteins to manage COVID-19 in its early stages. Cambrigde, April 12, 2021.- The findings appeared online in the journal Nature Medicine in March 2021. Based on their analyses, the researchers are calling forContinuar Leyendo

Cancer therapy in recent times relies on the use of several drugs derived from biological sources including different bacteria and viruses, among others. However, these bio-based drugs get easily degraded and therefore inactivated on administration into the body. Thus, effective delivery to and release of these drugs at target tumorContinuar Leyendo

Social distancing and lockdowns may have reduced the spread of COVID-19, but researchers from Penn State College of Medicine also report those actions may have affected clinical researchers’ ability to finish trials. Study completion rates dropped worldwide between 13% and 23%, depending on the type of research sponsor and geographicContinuar Leyendo

El trabajo liderado por el doctor Gonzalo Jorquera, investigador de la U. de Valparaíso, fue publicado en la revista “Diabetologia”, de la Sociedad Europea para el estudio de la Diabetes, una de las más importantes del mundo en la investigación en endocrinología y metabolismo. Valparaíso, 08 de Abril de 2021.-Continuar Leyendo